GlassScriptPhysician profile
Jennifer Chen
NPI 1982920716
$3,154.73
in general payments reported to CMS, 2019-2025
17 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.28 · 2021: $593 · 2022: $83.20 · 2023: $189 · 2024: $1,611 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,661 · Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,661.26 |
| Food and Beverage | $763.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,270.44 | 2024-2025 | Triclip |
| Philips North America LLC | $635.17 | 2022-2024 | (9525) Intracardiac Und |
| Esperion Therapeutics, INC. | $423.01 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.72 | 2021-2025 | Jardiance |
| Heartflow, INC. | $144.94 | 2023 | Ffrct |
| Gilead Sciences, INC. | $108.86 | 2025 | Vemlidy |
| Kowa Pharmaceuticals America, INC. | $60.40 | 2022-2023 | Livalo |
| Ebr Systems, INC. | $40.33 | 2025 | |
| Edwards Lifesciences Corporation | $39.74 | 2025 | Pascal |
| Boston Scientific Corporation | $39.22 | 2025 | Avvigo Guidance System |
| Bard Peripheral Vascular, INC. | $32.95 | 2025 | Venclose Maven Catheter |
| Astrazeneca Pharmaceuticals LP | $31.25 | 2019 | |
| Merz Pharmaceuticals, LLC | $28.59 | 2025 | Xeomin |
| Novartis Pharmaceuticals Corporation | $26.41 | 2025 | |
| Amarin Pharma, INC. | $23.08 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.03 | 2019 | |
| Abbvie INC. | $13.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.